Funding for this research was provided by:
Consejo Nacional de Ciencia y Tecnología (311783, FOSISS-289788)
Received: 19 August 2020
Accepted: 7 October 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: This study is being carried out in accordance with the recommendations of the institutional Ethics in Human Research Committees. All participants will have given written informed consent to one of the study investigators in accordance with the Declaration of Helsinki. The protocol was approved by the Ethics in Human Research Committees of <i>Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán</i> (INCMNSZ)<i>,</i> and <i>Instituto Nacional de Cardiología Ignacio Chávez</i>, both in Mexico City, Mexico<i>;</i> and <i>Comisión Federal para la Protección contra Riesgos Sanitarios</i> (COFEPRIS), the Federal Mexican pharmacological regulatory commission.
: Not applicable.
: Pablo F Belaunzarán-Zamudio is an Associated Editor for the HIV and co-infections section of BMC Infectious Diseases.